Social Care

Lord Mackinlay of Richborough Excerpts

Wednesday 25th October 2017 Commons Chamber

[Barbara Keeley]

Very much so. I thank my hon. Friend for making that point. It is concerning that planned consultations or discussions about future policy should focus so much on older people, when the needs of people with disabilities and learning disabilities are so important. We talked about learning disabilities in a debate last week.

Labour will fill the policy vacuum that exists around social care under this Government. Over the coming months, we will consult experts on how we can move from the current broken system of care to a sustainable service for the long term. We will look at funding options for social care in the long term, such as wealth taxes, an employer care contribution or a new social care levy. Those experts will help clarify the options for funding our planned national care service. Our approach will be underpinned by the principle of pooled risk, so that no one faces catastrophic care costs as they do now or as they would under the Conservative party’s dementia tax.

Our plans are for a national care service. They are based on a consultation—the “Big Care Debate”—that involved 68,000 people. People in that consultation told us that they needed a system that will support them and their families to live the lives they want, that will treat everyone with dignity and respect and that will give them choice and control over their care. I believe those needs remain the same, and they will be at the heart of our ambition for social care.

I urge hon. Members from all parties to vote with the Opposition today so that we can set the foundations for a safer, more sustainable and higher quality care system for the future and reassure those who have become worried about the Conservative party’s dementia tax mess.

[Craig Mackinlay (South Thanet) (Con)]

I am always very impressed by the hon. Lady’s knowledge in this area, but just to clarify, did I hear her say that she was considering wealth taxes as a means to pay for these proposals? She talked about a policy vacuum, but I would be interested to hear how the money vacuum would be filled. I am also somewhat concerned—I hope she will explain this—that a national care system rather puts families aside.

[Barbara Keeley]

I am obviously coming to the end of my speech, but I recommend that the hon. Gentleman, if he is interested, read a number of documents. The Labour Government produced a White Paper for a national care service; it is still available, and I advise him to look at it. Given everything I have said about carers in this speech, there is no way that we would not include them as an important part of our proposals, but the burden should not just be dumped on them. Carers should be partners in care, and they should be supported so that they have a life of their own. It is said that the only numbers put on the Conservative party’s proposals for a dementia tax in its manifesto were the page numbers. The Labour party has produced the document I have here—“Funding Britain’s Future”—and a fully costed manifesto. If the hon. Gentleman has a bit more time for reading, I advise him to go to our manifesto and to look at how we laid out the options. We laid them out; we did not get into a mess, as the Conservative party did, and try to change things after four days. We will take this issue forward; we will not kick it into the long grass, as the Conservative party is trying to do.

Community Pharmacies

Lord Mackinlay of Richborough Excerpts

Wednesday 2nd November 2016 Commons Chamber

[Paul Scully]

My hon. Friend makes a very good point.

Independent pharmacies in Sutton conduct medicine reviews, which we have heard about, and often deliver to their patients’ homes. They therefore see people in their own environment, rather than in a GP surgery. They get to see what is left in the bathroom cabinet, forgotten about or set aside. Ignoring or forgetting to take prescribed medicines causes such a lot of waste. There is an estimated £300 million a year that could go to other front-line services. By seeing the patient in their own environment, the pharmacist can make an assessment based on the patient’s everyday life, rather than just a snapshot, which might be affected by things such as white coat syndrome.

Consultation room services, such as sexual health, smoking cessation and minor ailment services, have to be a good thing for the NHS and should be encouraged. From what I have seen in pharmacies, there is still too much of a disconnect in the exchange of patient information between GPs and pharmacists. If advice and treatment are to work, they must be done in full knowledge of the patient’s background and medical history.

I understand the concerns that have driven the review and the changes that we are debating. The current funding system encourages pharmacy companies to open numerous low prescription volume sites, especially with the guaranteed fixed payment of £25,000 a year, regardless of size, quality or local demand. Some 40% of pharmacies are in clusters of two or more, with 20% being within 10 minutes’ walk of at least two others. That is reflected in Sutton. There are three in Worcester Park, four in north Cheam and six in and around Sutton High Street.

My concern is that any closures that result from these changes are more likely to come from the independent portion—those pharmacists who go beyond the corporate approach, often offering services at no cost or at a loss, because it is the right thing to do; those who prioritise the service that patients need, rather than shareholder value. Responding to customers on a personal basis allows independent pharmacists to consider savings such as generic substitution. We talk about a seven-day NHS, but pharmacists need to be set free to offer a high street NHS.

The Government’s changes recognise much of what pharmacists’ bodies have been raising. The changes seek to move pharmacists away from being reliant primarily on dispensing income, which is more vulnerable in the long term, towards services. Repeat prescriptions and those who come in via the 111 service will be directed to pharmacies, rather than out-of-hours GPs. For the first time, pharmacies will be paid for the quality of the services they provide, not just the volume. There is much to be welcomed, but I urge the Minister to keep the impact of the changes on independent pharmacies, which are often family run, under constant review.

[Craig Mackinlay (South Thanet) (Con)]

My hon. Friend is speaking very well for the independent pharmacy sector. It is those pharmacies that we should be protecting the most, because they are the first triage that saves the NHS money down the line. They can save a lot of money for the general NHS drugs bill by knowing their patients well, knowing the GPs and suggesting something cheaper. I am not convinced that the Government have looked into that aspect closely enough.

[Paul Scully]

I thank my hon. Friend for his comments. I have spoken about generic substitution and some of the things LloydsPharmacy and family-run services are doing in the consultation room. Those things are to be welcomed, encouraged and boosted.

I urge the Minister, in the coming months and years, to keep the impact of the changes on independent, often family-run pharmacists under constant review, because I and many others in this place certainly will.

Contaminated Blood

Lord Mackinlay of Richborough Excerpts

Tuesday 12th April 2016 Commons Chamber

[Craig Mackinlay (South Thanet) (Con)]

In my view, real progress has been made, culminating in January 2016 with the Under-Secretary of State for Health, the hon. Member for Battersea (Jane Ellison), outlining an additional £100 million, with principles laid out as part of the consultation.

As the Minister knows. I have followed this issue incredibly closely during my time in the House. It has been raised with me repeatedly by my constituent and victim Steve Dymond—the Minister is familiar with his case. Another constituent, Mr Lee Stay, has made himself known to me, and I am here to speak for him too. In the 1980s, he attended the Lord Mayor Treloar college in Hampshire, which was a specialist boarding school with a wing for haemophiliac children. He was given factor VIII, but the blood products contained HIV and hep C. He had a liver transplant, and now suffers from Burkitt lymphoma. He cannot work, and his house has been repossessed.

I know rather more about Mr Dymond, who is a tireless campaigner and advocate for his fellow victims. He has not been able to attend today. He is extremely unwell as a result of his hepatitis C infection, but I know that he will be watching and that the whole House will wish him and all the victims we have heard about today recovery where at all possible. Steve Dymond was afflicted by hepatitis C through no fault of his own, having received contaminated blood as treatment for haemophilia, as we have heard from many cases this afternoon. Every day of Steve’s life since his infection has been lived through the lens of that condition. His capacity to work, to enjoy time with his family, to travel, to holiday and to do all those normal things that we take for granted has been fundamentally affected by his infection.

[Mark Pawsey (Rugby) (Con)]

My hon. Friend refers to family. I want to raise the case of a constituent of mine, which I had the opportunity to talk about when we last discussed this matter in July 2015. My constituent, who was affected by contaminated blood, was trying to have a child through IVF. The couple were entitled to one round of IVF through the normal procedures, but they applied for a second round. Despite the fact that their fertility was affected by contaminated blood, they were denied a second round of IVF and had to spend £8,000 of their family money in order to conceive a second child, who has just been born, to their delight. Does my hon. Friend agree that, in the context of family and support, it is extraordinary that my constituent had to go through such hardship to extend his family?

[Craig Mackinlay]

I entirely agree and thank my hon. Friend for his comments. That example highlights the issues faced not only by the victim, but by the family from young to old. It is remarkable that special cases such as he describes are not recognised by the system. I hope that as part of the review those instances will be resolved.

What happened to Steve, Lee and all the others whom we have heard about today was wrong. In many cases it was avoidable. They were blameless victims who were handed debilitating, dehumanising—as my hon. Friend’s example shows—and degenerative infections that have caused heartache to all those affected. Although responsibility obviously lies with the commercial suppliers of the products, the NHS unwittingly administered them, and society owes the victims a debt. We must do the best we can to alleviate the pain and illness that victims have suffered. The decision that this House and the Government take should place those victims front and centre.

There are two threads to the approach that we should take. First, we must provide treatment for the victims, who suffer from various complex conditions and symptoms that require advanced and expensive care. It is right that we invest in the care and treatment available for those conditions, and in research. Thankfully, medical advances are making rapid progress. Secondly, we must ensure that as much restitution as possible is made to those who have suffered in that way.

[Mary Robinson (Cheadle) (Con)]

My hon. Friend rightly talks about the blameless victims and the need for compensation. My constituent, who wishes not to be named, asked me about her husband, who was infected in the late 1970s and 1980s. He was a mild haemophiliac whose life was not previously at risk, but he is now living with conditions caused by contaminated blood. Does my hon. Friend agree that in the consultation on the proposals it is important that we consider the long-term impact on such families?

[Craig Mackinlay]

My hon. Friend makes a powerful point. The issue is not just money or the obvious conditions. A holistic approach is needed to what those families have faced. The example that she gives of a minor condition is truly shocking.

Money has been discussed at length this afternoon. Money can never bring back what victims have lost, but it is important that the Government do what they can to bring dignity to the shortened lives of many of those who suffer.

I welcome what the Government have done in relation to treatment. On the new generation of drug treatments, the National Institute for Health and Care Excellence is developing guidance on three further treatments, and NHS England announced last year that it had made available £190 million so that patients with confirmed cirrhosis from hepatitis C can benefit from new treatment options. The Department of Health estimates that around 550 individuals infected with hepatitis C through NHS-supplied blood and blood products can now access the new treatments under the NHS’s interim commissioning policies.

Medical advances will continue, and there will be beneficial new treatments around the corner, which I hope will stem much liver damage. They may prove to be the salvation for many, but it is early days in this pioneering field of research. There remains some confusion from victims about where the money is coming from, so I would welcome the Minister’s clarification on that. I will continue to push for the best treatments available, and for research so that even better treatments are around the corner.

On support for victims, I await the Government’s conclusions on the current consultation. Central to all of this is the need to bring dignity to all those afflicted. Victims tell me that they feel that the current system has in some way belittled them and that it is insufficient. Clearly a more suitable settlement for such victims is needed. Care for bereaved next of kin, as we have heard this afternoon, remains at the forefront of victims’ minds. The settlement needs to be flexible, and I await the proposals that the Government bring forward to address these concerns.

It saddens me that some victims, including those in my own constituency, do not view the Minister as being committed to this cause. I personally refute that. I have found her to be diligent and dedicated to this tragedy. She has been honourable throughout. She has spoken honestly with me, and with great compassion. On every occasion I have spoken with her about the issue, often late in the Division Lobby, she has been both knowledgeable and committed to righting this wrong. Campaigners and victims, such as Steve and Lee, will not settle for a halfway house. Although we can never turn the clock back, I am confident that the Government will do what they can to give dignity to all those affected.

[Several hon. Members rose—]

Victims of Contaminated Blood: Support

Lord Mackinlay of Richborough Excerpts

Wednesday 16th December 2015 Commons Chamber

[Jane Ellison]

This certainly has not been kicked into the long grass. As I have told the House, it is my intention to consult in January. I have said before, but it is worth repeating, that although we are working to establish a fair resolution, liability has not been established in the majority of cases, so it is not appropriate to talk about compensation payments, particularly on the scale that some campaigners and colleagues envisage. I have been open about that for many months. The hon. Lady is right to make the point about treatments, and all those things will be considered. I can confirm to the House that, although the £25 million was allocated to be spent in this financial year, it will be carried forward. The money that the Prime Minister announced in March was to support the transition of the scheme, which we envisaged beginning next spring, following the consultation. The money will support that, and it will be carried forward.

[Craig Mackinlay (South Thanet) (Con)]

I congratulate the hon. Member for Kingston upon Hull North (Diana Johnson) on securing the urgent question. I speak today on behalf of a constituent, a Mr Steve Dymond, who has hepatitis C as a result of contaminated blood products. Although he is in remission, a normal life for him is impossible. I know that new drugs and treatments are available. Will the Minister assure me that those advanced new treatments will be available to all sufferers without restrictions? I hope that, despite this delay, the closure we need will be delivered very shortly. This is a big subject in my part of Kent. It is trailed massively in the Kent on Sunday, which covers it regularly. We need closure and those affected need certainty in their lives. Can the Minister assure me of that?

[Jane Ellison]

I have corresponded directly with Mr Dymond’s partner, so I know the level of suffering he endures. On the new treatments, the drug landscape on hepatitis C infection, which is very different from even a couple of years ago, is uppermost in my mind as I consider how to reform the scheme and support those who suffer.